<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705764/" ref="ordinalpos=3566&amp;ncbi_uid=1951036&amp;link_uid=PMC2705764" image-link="/pmc/articles/PMC2705764/figure/fig1/" class="imagepopup">Figure 1.  From: New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor. </a></div><br /><div class="p4l_captionBody">Upon binding of insulin, the IR undergoes autophosphorylation which enables the receptor to have a kinase activity and phosphorylates various cytoplasmic substrates, such as IRSs. From this point, signaling proceeds via a variety of signaling pathways (i.e., PI3K signaling pathway, Ras and MAP kinase cascade) that are responsible for the metabolic, growth-promoting and mitogenic effects of insulin.</div></div>